Cargando…

Sex Differences in Spironolactone and the Active Metabolite Canrenone Concentrations and Adherence

We aim to investigate sex differences in blood concentrations of spironolactone and the active metabolite canrenone in resistant hypertension patients. Furthermore, sex differences in adherence for spironolactone and other antihypertensive drugs (AHDs) were studied. The patients in this post hoc stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peeters, Laura E. J., Tjong, Leonardien K., Rietdijk, Wim J. R., van Gelder, Teun, Koch, Birgit C. P., Versmissen, Jorie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773364/ https://www.ncbi.nlm.nih.gov/pubmed/35052816 http://dx.doi.org/10.3390/biomedicines10010137

Ejemplares similares

Simultaneous Identification and Quantification of Canrenone and 11-α-Hydroxy-Canrenone by LC-MS and HPLC-UVD
por: Huang, Da-Ming, et al.
Publicado: (2011)

DiffErenCes in AntihypertenSive Drug Blood Levels in Patients with HypertensiON (DECISION): Protocol for a Prospective Observational Study Comparing Pharmacokinetics and Pharmacodynamics Between Young and Elderly Patients
por: Hassan, Dimokrat, et al.
Publicado: (2022)

Monitoring antihypertensive drug concentrations to determine nonadherence in hypertensive patients with or without a kidney transplant
por: Peeters, Laura E.J., et al.
Publicado: (2023)

Development and Validation of a Dried Blood Spot Assay Using UHPLC-MS/MS to Identify and Quantify 12 Antihypertensive Drugs and 4 Active Metabolites: Clinical Needs and Analytical Limitations
por: Peeters, Laura E. J., et al.
Publicado: (2022)

A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib
por: Atiq, Ferdows, et al.
Publicado: (2016)

Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia
por: Agalakova, Natalia I., et al.
Publicado: (2022)

Introducing the importance and difficulties of a three-step approach to improve nonadherence to antihypertensive drugs: a case series
por: Peeters, Laura E.J., et al.
Publicado: (2022)

The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients
por: Vicenzi, Marco, et al.
Publicado: (2020)

A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency
por: Atiq, Ferdows, et al.
Publicado: (2015)

Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals
por: Atiq, Ferdows, et al.
Publicado: (2018)

Effects of Impeller Geometry on the 11α-Hydroxylation of Canrenone in Rushton Turbine-Stirred Tanks
por: Rong, Shaofeng, et al.
Publicado: (2021)

The effect of combining therapeutic drug monitoring of antihypertensive drugs with personalised feedback on adherence and resistant hypertension: the (RHYME-RCT) trial protocol of a multi-centre randomised controlled trial
por: Peeters, L. E. J., et al.
Publicado: (2023)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

A new method to calculate intra‐patient variability in tacrolimus concentrations
por: van Gelder, Teun
Publicado: (2021)

Vascular medicine and cardio-oncology – A new, evolving clinical frontier
por: Versmissen, Jorie, et al.
Publicado: (2020)

Clinical effects of antiplatelet drugs and statins on D‐dimer levels
por: Schol‐Gelok, Suzanne, et al.
Publicado: (2018)

Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related Pain
por: Agema, Bram C., et al.
Publicado: (2021)

The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
por: Schreuder, Michelle M., et al.
Publicado: (2021)

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

Trigeminovascular effects of propranolol in men and women, role for sex steroids
por: Rubio‐Beltrán, Eloísa, et al.
Publicado: (2022)

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
por: Angus, Lachlan, et al.
Publicado: (2019)

Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
por: Bosone, Daniele, et al.
Publicado: (2016)

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial
por: Schol‐Gelok, Suzanne, et al.
Publicado: (2020)

A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients
por: Derosa, Giuseppe, et al.
Publicado: (2018)

Effect of spironolactone on pain responses in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2010)

Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017)

Imatinib and spironolactone suppress hepcidin expression
por: Mleczko-Sanecka, Katarzyna, et al.
Publicado: (2017)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

Doxazosin treatment of phaeochromocytoma during pregnancy: placental transfer and disposition in breast milk
por: Versmissen, Jorie, et al.
Publicado: (2016)

The effect of spironolactone on diastolic function in haemodialysis patients
por: Hauser, T., et al.
Publicado: (2021)

Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study
por: Sablerolles, Roos S G, et al.
Publicado: (2021)

No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial
por: Ferreira, João Pedro, et al.
Publicado: (2021)

DRESS Syndrome Secondary to Spironolactone with Atypical Presentation
por: Bains, Anupama, et al.
Publicado: (2020)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
por: Renz, Susanne, et al.
Publicado: (2021)

Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”
por: Zhao, Ling-Yue, et al.
Publicado: (2019)

Efficacy and Safety of High Potent P2Y(12) Inhibitors Prasugrel and Ticagrelor in Patients With Coronary Heart Disease Treated With Dual Antiplatelet Therapy: A Sex‐Specific Systematic Review and Meta‐Analysis
por: Schreuder, Michelle M., et al.
Publicado: (2020)

Use, tolerability and compliance of spironolactone in the treatment of heart failure
por: Lachaine, Jean, et al.
Publicado: (2011)

Agranulocytosis Associated With Spironolactone Therapy: A Case Report
por: Fershko, Adam A., et al.
Publicado: (2011)

S47. ADD-ON SPIRONOLACTONE FOR THE TREATMENT OF SCHIZOPHRENIA (SPIRO TREAT)
por: Roeh, Astrid, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g4k7grun46he9c9na7lpcqhpa1